Bluejay Diagnostics (BJDX) Non Operating Income (2020 - 2026)

Bluejay Diagnostics has disclosed Non Operating Income across 7 years of filings, most recently posting $731.0 for Q1 2026.

• Non Operating Income for Q1 2026 came in at $731.0, down 89.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $51706.0 (down 92.01% YoY), and the FY2025 annual result was $104489.0, down 19.02% from the prior year.
• Non Operating Income came in at $731.0 for Q1 2026 at Bluejay Diagnostics, down from $31935.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $729859.0 in Q4 2024 to a low of -$149711.0 in Q3 2022.
• The 5-year median for Non Operating Income is $43235.0 (2023), against an average of $77898.3.
• Peak annual rise in Non Operating Income reached 769.07% in 2024, while the deepest fall reached 378.37% in 2024.
• Bluejay Diagnostics' Non Operating Income stood at $214994.0 in 2022, then slumped by 60.94% to $83982.0 in 2023, then surged by 769.07% to $729859.0 in 2024, then slumped by 95.62% to $31935.0 in 2025, then tumbled by 97.71% to $731.0 in 2026.
• The last three Non Operating Income figures came in at $731.0 (Q1 2026), $31935.0 (Q4 2025), and $19315.0 (Q3 2025), per Business Quant data.